208 related articles for article (PubMed ID: 18807138)
1. Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells.
Morishima S; Shibata MA; Ohmichi M; Otsuki Y
Med Mol Morphol; 2008 Sep; 41(3):132-8. PubMed ID: 18807138
[TBL] [Abstract][Full Text] [Related]
2. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.
Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ
Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells.
Kim HT; Kim BC; Kim IY; Mamura M; Seong DH; Jang JJ; Kim SJ
J Biol Chem; 2002 Sep; 277(36):32510-5. PubMed ID: 12084714
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
9. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes.
Mirzapur P; Khazaei MR; Moradi MT; Khazaei M
Life Sci; 2018 Jul; 205():45-53. PubMed ID: 29705353
[TBL] [Abstract][Full Text] [Related]
11. A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes.
Hattori Y; Kojima T; Kato D; Matsubara H; Takigawa M; Ishiguro N
Biochem Biophys Res Commun; 2012 May; 421(3):418-24. PubMed ID: 22480687
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.
Shibata MA; Morimoto J; Shibata E; Kurose H; Akamatsu K; Li ZL; Kusakabe M; Ohmichi M; Otsuki Y
BMC Cancer; 2010 Oct; 10():566. PubMed ID: 20958960
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.
Kim IY; Kim BC; Seong DH; Lee DK; Seo JM; Hong YJ; Kim HT; Morton RA; Kim SJ
Cancer Res; 2002 Sep; 62(18):5365-9. PubMed ID: 12235008
[TBL] [Abstract][Full Text] [Related]
14. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells.
Chen J; Mehta JL; Haider N; Zhang X; Narula J; Li D
Circ Res; 2004 Feb; 94(3):370-6. PubMed ID: 14684629
[TBL] [Abstract][Full Text] [Related]
15. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
Olivier S; Close P; Castermans E; de Leval L; Tabruyn S; Chariot A; Malaise M; Merville MP; Bours V; Franchimont N
Mol Pharmacol; 2006 May; 69(5):1615-23. PubMed ID: 16497877
[TBL] [Abstract][Full Text] [Related]
16. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
17. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.
Zhang Y; Bhavnani BR
BMC Neurosci; 2005 Feb; 6():13. PubMed ID: 15730564
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.
Hoffman KL; Lerner SP; Smith CL
Horm Cancer; 2013 Feb; 4(1):24-35. PubMed ID: 22965848
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
[TBL] [Abstract][Full Text] [Related]
20. Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells.
Park MT; Kang JA; Choi JA; Kang CM; Kim TH; Bae S; Kang S; Kim S; Choi WI; Cho CK; Chung HY; Lee YS; Lee SJ
Clin Cancer Res; 2003 Feb; 9(2):878-85. PubMed ID: 12576463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
